Nutrition, Inflammation, and Acute Pancreatitis

Table 6

Characteristics of randomised controlled trials of various enteral nutrition formulations.

Reference	Year	Intervention group	Control group	Number of patients
				Intervention group	Control group	Severe	Mild
McClave et al. [77]	1997	Semielemental EN	PN	15	15	6	24
Kalfarentzos et al. [70]	1997	Semielemental EN	PN	18	20	38	0
Windsor et al. [42]	1998	Polymeric EN	PN	16	18	13	21
Powell et al. [40]	2000	Polymeric EN	NN	13	14	27	0
Hallay et al. [78]	2001	EN with fibre + glutamine + arginine	EN with fibre	11	8	19	0
Olah et al. [79]	2002	Elemental EN	PN	41	48	17	72
Abou-Assi et al. [80]	2002	Elemental EN	PN	26	27	26	27
Olah et al. [81]	2002	EN with fibre + probiotics	EN with fibre	22	23	32	13
Gupta et al. [43]	2003	Polymeric EN	PN	8	9	17	0
Louie et al. [71]	2005	Semielemental EN	PN	10	18	28	0
Lasztity et al. [82]	2005	Polymeric EN + n-3 PUFAs	Polymeric EN	14	14	6	22
Pearce et al. [83]	2006	EN with fibre + glutamine + arginine + omega-3 fatty acids	EN with fibre	15	16	31	0
Tiengou et al. [84]	2006	Semielemental EN	Polymeric EN	15	15	19	11
Eckerwall et al. [41]	2006	Polymeric EN	PN	23	25	48	0
Petrov et al. [72]	2006	Semielemental EN	PN	35	34	69	0
Casas et al. [73]	2007	Semielemental EN	PN	11	11	22	0
Olah et al. [80]	2007	EN with fibre + probiotics	EN with fibre	33	29	62	0
Karakan et al. [85]	2007	EN with fibre	Polymeric EN	15	15	30	0
besselink et al. [86]	2008	EN with fibre + probiotics	EN with fibre	152	144	296	0
Qin et al. [87]	2008	Semielemental EN + probiotics	PN	36	38	19	55

EN: enteral nutrition; PN: parenteral nutrition; PUFA: polyunsaturated fatty acids.